Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Daunoxome |
| Trade Name | |
| Synonyms | Liposomal daunorubicin citrate |
| Drug Descriptions |
Daunoxome is a liposomal formulation of the anthracyline, daunorubicin and is FDA approved for HIV-associated Kaposi’s sarcoma (FDA.gov). |
| DrugClasses | Chemotherapy - Anthracycline 13 |
| CAS Registry Number | NA |
| NCIT ID | C2213 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cytarabine + Daunoxome | Cytarabine Daunoxome | 0 | 2 |
| Cytarabine + Daunoxome + Fludarabine | Cytarabine Daunoxome Fludarabine | 0 | 1 |
| Cytarabine + Daunoxome + Fludarabine + Methotrexate | Cytarabine Daunoxome Fludarabine Methotrexate | 0 | 1 |
| Daunoxome | Daunoxome | 0 | 1 |
| Daunoxome + Pembrolizumab | Daunoxome Pembrolizumab | 0 | 0 |